Twist Bioscience Corp — Form D/A

Twist Bioscience Corp of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2017-05-18. The offering totals $50.0M, of which $49.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Keith Marine CrandellDirectorSan Francisco, CA
Paul Marine ConleyDirectorSan Francisco, CA
Bob Marine RagusaDirectorSan Francisco, CA
Minqi Marine LiDirectorSan Francisco, CA
Rob Marine ChessDirectorSan Francisco, CA
William Marine BanyaiDirectorSan Francisco, CA
William Marine BanyaiExecutive OfficerSan Francisco, CA
Fred Marine CravesDirectorSan Francisco, CA
Bill Marine PeckExecutive OfficerSan Francisco, CA
Emily Marine LeproustDirectorSan Francisco, CA
Emily Marine LeproustExecutive OfficerSan Francisco, CA
Emily Marine LeproustPromoterSan Francisco, CA
Solange Marine GlaizeExecutive OfficerSan Francisco, CA
Keith James CrandellDirectorSan Francisco, CA
William Charles BanyaiDirectorSan Francisco, CA
William Charles BanyaiExecutive OfficerSan Francisco, CA
William Charles BanyaiPromoterSan Francisco, CA
Paul James ConleyDirectorSan Francisco, CA
Solange James GlaizeExecutive OfficerSan Francisco, CA
Rob James ChessDirectorSan Francisco, CA
Fred James CravesDirectorSan Francisco, CA
Bill James PeckExecutive OfficerSan Francisco, CA
Bill James PeckPromoterSan Francisco, CA
Nick James NaclerioDirectorSan Francisco, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2018-04-02D$85.0M$50.0M
2017-12-29D/A$75.0M$74.9M
2017-06-14D/A$63.2M$60.3M
2017-03-27D$33.2M$32.2M
2016-04-19D$2.6M$2.6M
2016-01-20D$61.0M$61.0M
2015-06-11D$37.0M$37.0M
2014-05-28D$26.5M$26.0M
2014-02-10D/A$9.3M$9.1M
2013-07-12D$9.0M$4.7M

More